DSM provides 2014 comparative figures

Royal DSM, the global Life Sciences and Materials Sciences company, today provides the investment community with comparative quarterly figures for 2014.

These comparative figures reflect the reclassification of the Polymer Intermediates cluster and the DSM Composite Resins business group to discontinued operations after the announced partnership for these businesses with CVC Capital Partners (CVC). DSM's Corporate Activities are also restated, since DSM's 65% stake in Sitech Services will be transferred as a result of the partnership with CVC. The restatement also reflects the sale of DSM Synres to Standard Investment and Euroresins to Cathay Investments, as previously announced.

The comparative figures can be found in the annex to this press release.

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

Or find us on:        

For more information: